Skip to search formSkip to main contentSkip to account menu

tolterodine

Known as: (+)-Tolterodine, Tolterodinum, Tolterodina 
A benzhydryl compound and a muscarinic receptor antagonist possessing both antimuscarinic and antispasmodic properties. Both tolterodine and its… 
National Institutes of Health

Related topics

Related topics

11 relations
24 HR tolterodine tartrate 2 MG Extended Release Oral CapsuleAngle Closure GlaucomaDecreased Bladder Contractility [PE]Hypersensitivity

Narrower (2)

Detroltolterodine tartrate 2 MG Oral Tablet

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending
Policy Points: Our study indicates that there are opportunities for cost savings in generic drug markets in Europe and the United… 
Highly Cited
2013
Highly Cited
2013
Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial.
Highly Cited
2006
Highly Cited
2006
Comparison of efficacy of oxybutynin and tolterodine for prevention of catheter related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study.
BACKGROUND Bladder discomfort related to intraoperative catheterization of urinary bladder is a distressing symptom and more so… 
Review
2005
Review
2005
Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly.
Highly Cited
2002
Highly Cited
2002
Efficacy of botulinum-a toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results.
Review
2002
Review
2002
Muscarinic receptor subtypes and management of the overactive bladder.
Highly Cited
2002
Highly Cited
2002
Tolterodine: As effective but better tolerated than oxybutynin in Asian patients with symptoms of overactive bladder
Background: This double‐blind, multicenter study compared the efficacy and tolerability of tolterodine (Pharmacia, Los Angeles… 
Highly Cited
1999
Highly Cited
1999
Clinical Efficacy and Safety of Tolterodine Compared to Oxybutynin and Placebo in Patients with Overactive Bladder
Abstract: This study compared the clinical efficacy (determined from micturition diaries) and safety of 12 weeks’ treatment with… 
Highly Cited
1998
Highly Cited
1998
Efficacy and safety of tolterodine in patients with detrusor instability: a dose-ranging study.
OBJECTIVE To investigate the efficacy and safety of tolterodine, a new antimuscarinic agent, and define the optimum dosage in… 
Highly Cited
1997
Highly Cited
1997
Pharmacokinetics and pharmacodynamics of tolterodine in man: a new drug for the treatment of urinary bladder overactivity.
The aim of this study was to determine the pharmacokinetics, pharmacodynamics, and safety of tolterodine following single oral… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)